Prognostic value and therapeutic targeting of XPO1 in chronic lymphocytic leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prognostic value and therapeutic targeting of XPO1 in chronic lymphocytic leukemia

Published:2023-02-04 Issue:6 Volume:23 Page:2651-2662
ISSN:1591-9528
Container-title:Clinical and Experimental Medicine
language:en
Short-container-title:Clin Exp Med

Author:

Xu Zhangdi,Pan Bihui,Miao Yi,Li Yue,Qin Shuchao,Liang Jinhua,Kong Yilin,Zhang Xinyu,Tang Jing,Xia Yi,Zhu Huayuan,Wang Li,Li Jianyong,Wu Jiazhu,Xu Wei

Funder

Young Scholars Fostering Fund of the First Affiliated Hospital of Nanjing Medical University

Nature Science Foundation for Youths of Jiangsu Province

National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10238-023-01003-6.pdf

Reference41 articles.

1. Hallek M, Shanafelt TD, Eichhorst B. Chronic lymphocytic leukaemia. Lancet. 2018;391(10129):1524–37.

2. Scarfo L, Ferreri AJ, Ghia P. Chronic lymphocytic leukaemia. Crit Rev Oncol Hematol. 2016;104:169–82.

3. Sharma S, Rai KR. Chronic lymphocytic leukemia (CLL) treatment: So many choices, such great options. Cancer. 2019;125(9):1432–40.

4. Albiol N, Arguello-Tomas M, Moreno C. The road to chemotherapy-free treatment in chronic lymphocytic leukaemia. Curr Opin Oncol. 2021;33(6):670–80.

5. Hutten S, Kehlenbach RH. CRM1-mediated nuclear export: to the pore and beyond. Trends Cell Biol. 2007;17(4):193–201.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The nuclear export protein exportin‐1 in solid malignant tumours: From biology to clinical trials;Clinical and Translational Medicine;2024-05

2. Case report: Safety and efficacy of synergistic treatment using selinexor and azacitidine in patients with atypical chronic myeloid leukemia with resistance to decitabine;Frontiers in Oncology;2024-02-07

3. Anti-tumor activity of selinexor in combination with antineoplastic agents in chronic lymphocytic leukemia;Scientific Reports;2023-10-07

4. Selinexor and Other Selective Inhibitors of Nuclear Export (SINEs)—A Novel Approach to Target Hematologic Malignancies and Solid Tumors;Drugs and Drug Candidates;2023-05-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3